Donald Trump's appointment of Robert F Kennedy Junior as health czar means interesting times for US-focused ASX life sciences ...

Bavarian Nordic, with a diverse vaccine portfolio and $340 million in contracts for 2025, offers growth potential for ...

Robert F. Kennedy Jr.'s nomination to lead HHS is causing cautious concern among investors. Here's which companies and stocks ...

In a report released on November 15, Jason Gerberry from Bank of America Securities maintained a Buy rating on Vaxcyte (PCVX – Research ...

Shares are mixed in Europe and Asia after U.S. stocks fell to their worst loss since Election Day. Japan's benchmark lost 1.1 ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

Trump announced Thursday he'll nominate Robert F. Kennedy Jr. to be secretary of the Health and Human Services Department, ...

Pfizer's stock dropped 4.3 percent while Moderna's fell 3.1 percent and Novavax saw a 2.8 percent dip in its stock Friday ...

The standout company among those yet to report is Nvidia Corp. (NVDA), which is scheduled to announce quarterly results on Wednesday.

U.S. stocks tumbled Friday as the "Trump bump" that Wall Street got from last week's presidential election, along with a cut ...